Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Breast Cancer

Fluorouracil-epirubicin-navelbine deemed effective in advanced breast cancer

"A phase II study was carried out to determine the safety and efficacy of the combination of FEN as first-line chemotherapy in advanced breast cancer (BC). Thirty-four women with advanced BC, aged 32-75 years (median 59), previously untreated for recurrence, were enrolled in the study. The treatment consisted of fluorouracil 600 mg/m² on day 1, epirubicin 75 mg/m² on day 1 and vinorelbine 25 mg/m² on days 1 and 8, every 3 weeks, up to a maximum of 9 cycles," scientists in Greece reported.

...

• View Other Issues of Women's Health Weekly
  
• View Other NewsRx Publications